-
1
-
-
3042806975
-
Detecting, verification and quantification of ADRs
-
Stricker B, Psaty BM. Detecting, verification and quantification of ADRs. BMJ 2004; 329: 44-7
-
(2004)
BMJ
, vol.329
, pp. 44-47
-
-
Stricker, B.1
Psaty, B.M.2
-
2
-
-
0025457997
-
Technology assessment of pharmaceuticals: The necessity of user perspective
-
Hansen EH. Technology assessment of pharmaceuticals: the necessity of user perspective. Cah Sociol Demogr Med 1990; 30: 313-27
-
(1990)
Cah Sociol Demogr Med
, vol.30
, pp. 313-327
-
-
Hansen, E.H.1
-
3
-
-
0026664334
-
Technology assessment in a user perspective: Experiences with drug technology
-
Hansen EH. Technology assessment in a user perspective: experiences with drug technology. Int J Technol Assess Health Care 1992; 8: 150-65
-
(1992)
Int J Technol Assess Health Care
, vol.8
, pp. 150-165
-
-
Hansen, E.H.1
-
6
-
-
0031903233
-
The role of the WHO programme on international drug monitoring in coordinating worldwide drug safety efforts
-
DOI 10.2165/00002018-199819010-00001
-
Olsson S. The role of theWHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf 1998; 19: 1-10 (Pubitemid 28353790)
-
(1998)
Drug Safety
, vol.19
, Issue.1
, pp. 1-10
-
-
Olsson, S.1
-
7
-
-
34548656551
-
Pharmacovigilance in developing countries
-
DOI 10.1136/bmj.39323.586123.BE
-
Pirmohamed M, Atuah KN, Dodoo AN, et al. Pharmacovigilance in developing countries. BMJ 2007; 335: 462 (Pubitemid 47401595)
-
(2007)
British Medical Journal
, vol.335
, Issue.7618
, pp. 462
-
-
Pirmohamed, M.1
Atuah, K.N.2
Dodoo, A.N.O.3
Winstanley, P.4
-
8
-
-
48349102509
-
Substandard medicines in resource-poor settings: A problem that can no longer be ignored
-
Caudron JM, Ford N, Henkens M, et al. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health 2008; 13: 1062-72
-
(2008)
Trop Med Int Health
, vol.13
, pp. 1062-1072
-
-
Caudron, J.M.1
Ford, N.2
Henkens, M.3
-
9
-
-
70349970392
-
Consumer reporting of adverse drug reactions: A retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006
-
Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009; 32: 1067-74
-
(2009)
Drug Saf
, vol.32
, pp. 1067-1074
-
-
Aagaard, L.1
Nielsen, L.H.2
Hansen, E.H.3
-
10
-
-
0030497560
-
US adverse drug reaction surveillance 1989-1994
-
DOI 10.1002/(SICI)1099-1557(199611)5:6<393::AID-PDS235>3.0.CO;2-H
-
Faich GA. US adverse drug reaction surveillance 1989-1994. Pharmacoepidemiol Drug Saf 1996; 5: 393-8 (Pubitemid 27062321)
-
(1996)
Pharmacoepidemiology and Drug Safety
, vol.5
, Issue.6
, pp. 393-398
-
-
Faich, G.A.1
-
11
-
-
59049100725
-
Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: An overview of reports 2003-2007
-
Johann-Liang R, Wyeth J, Chen M, et al. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007. Pharmacoepidemiol Drug Saf 2009; 18: 24-7
-
(2009)
Pharmacoepidemiol Drug Saf
, vol.18
, pp. 24-27
-
-
Johann-Liang, R.1
Wyeth, J.2
Chen, M.3
-
12
-
-
0027967850
-
Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations
-
Figueras A, Capella D, Castel JM, et al. Spontaneous reporting of adverse drug reactions to non-steroidal antiinflammatory drugs: a report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations. Eur J Clin Pharmacol 1994; 47: 297-303 (Pubitemid 24363330)
-
(1994)
European Journal of Clinical Pharmacology
, vol.47
, Issue.4
, pp. 297-303
-
-
Figueras, A.1
Capella, D.2
Castel, J.M.3
Laporte, J.R.4
-
13
-
-
34248380839
-
Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond
-
DOI 10.1080/17441690601063299, PII 777207885, Global Health Council's 2006 International Conference
-
Huff-Rousselle M, Simooya O, Kabwe V, et al. Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond. Glob Public Health 2007; 2: 184-203 (Pubitemid 46736530)
-
(2007)
Global Public Health
, vol.2
, Issue.2
, pp. 184-203
-
-
Huff-Rousselle, M.1
Simooya, O.2
Kabwe, V.3
Hollander, I.4
Handema, R.5
Mwango, A.6
Mwape, E.7
-
14
-
-
52149092177
-
The quality of analysis of adverse drug reaction reports in Shanghai during 2003-2007
-
Cheng W, Li Y-C, Fu Z, et al. The quality of analysis of adverse drug reaction reports in Shanghai during 2003-2007. Pharm Care Res 2008; 8: 276-80
-
(2008)
Pharm Care Res
, vol.8
, pp. 276-280
-
-
Cheng, W.1
Li, Y.-C.2
Fu, Z.3
-
15
-
-
77954936451
-
Establishing pharmacovigilance programs in resource-limited settings: The example of treating malaria
-
Metha U, Allen E, Barnes Kl. Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria. Expert Rev Clin Pharmacol 2010; 3: 509-25
-
(2010)
Expert Rev Clin Pharmacol
, vol.3
, pp. 509-525
-
-
Metha, U.1
Allen, E.2
Kl, B.3
-
16
-
-
50649103021
-
Spontaneous adverse drug reaction reporting in rural districts of Mozambique
-
Sevene E, Mariano A, Mehta U, et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf 2008; 31: 867-76
-
(2008)
Drug Saf
, vol.31
, pp. 867-876
-
-
Sevene, E.1
Mariano, A.2
Mehta, U.3
-
17
-
-
77954724803
-
Pharmacovigilance activities in 55 low-and middle-income countries: A questionnaire-based analysis
-
Olsson S, Pal SN, Stergachis A, et al. Pharmacovigilance activities in 55 low-and middle-income countries: a questionnaire-based analysis. Drug Saf 2010; 33: 689-703
-
(2010)
Drug Saf
, vol.33
, pp. 689-703
-
-
Olsson, S.1
Pal, S.N.2
Stergachis, A.3
-
18
-
-
84876798422
-
-
WHO Collaborating Centre for International Drug Monitoring [online]. Available from URL [Accessed 2010 Apr 21]
-
WHO Collaborating Centre for International Drug Monitoring. WHO programme 2010 [online]. Available from URL: http://www.who-umc.org/DynPage.aspx?id=13140 &mn=1514 [Accessed 2010 Apr 21]
-
(2010)
WHO Programme
-
-
-
19
-
-
33846120161
-
Patient reporting of suspected adverse drug reactions: A review of published literature and international experience
-
Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2006; 63: 148-56
-
(2006)
Br J Clin Pharmacol
, vol.63
, pp. 148-156
-
-
Blenkinsopp, A.1
Wilkie, P.2
Wang, M.3
-
20
-
-
23944510123
-
-
The World Bank Group [online]. Available from URL [Accessed 2010 Apr 8]
-
The World Bank Group. Country classifications 2010 [online]. Available from URL: http://data.worldbank.org/about/country-classifications [Accessed 2010 Apr 8]
-
(2010)
Country Classifications
-
-
-
24
-
-
84876796241
-
World population prospects
-
United Nations Department of Economic and Social Affairs (DESA) Population Division, Population Estimates and Projections Section [online]. Available from URL [Accessed 2011 Apr 3]
-
United Nations. World population prospects. Annual population 1950-2010 both sexes. Department of Economic and Social Affairs (DESA), Population Division, Population Estimates and Projections Section, 2010 [online]. Available from URL: http://esa.un.org/wpp/Excel-Data/population.htm [Accessed 2011 Apr 3]
-
(2010)
Annual Population 1950-2010 Both Sexes
-
-
-
25
-
-
79952340261
-
Assessment of global reporting of adverse drug reactions for antimalarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
-
Kuemmerle A, Dodoo AN, Olsson S, et al. Assessment of global reporting of adverse drug reactions for antimalarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Malar J 2011 9; 10: 57
-
(2011)
Malar J
, vol.9
, Issue.10
, pp. 57
-
-
Kuemmerle, A.1
Dodoo, A.N.2
Olsson, S.3
-
27
-
-
34748893542
-
Malaria pharmacovigilance in Africa: Lessons from a pilot project in Mpumalanga Province, South Africa
-
Mehta U, Durrheim D, Mabuza A, et al. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpuamlanga Province, South Africa. Drug Saf 2007; 30: 899-910 (Pubitemid 47481445)
-
(2007)
Drug Safety
, vol.30
, Issue.10
, pp. 899-910
-
-
Mehta, U.1
Durrheim, D.2
Mabuza, A.3
Blumberg, L.4
Allen, E.5
Barnes, K.I.6
|